scispace - formally typeset
D

Di Huang

Researcher at Wuhan University

Publications -  11
Citations -  2721

Di Huang is an academic researcher from Wuhan University. The author has contributed to research in topics: Guideline & Critical appraisal. The author has an hindex of 7, co-authored 11 publications receiving 1783 citations.

Papers
More filters
Journal ArticleDOI

Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?

TL;DR: This review introduced methodological quality assessment tools for randomized controlled trial, animal study, non-randomized interventional studies, qualitative study, outcome measurement instruments, systematic review and meta-analysis, and clinical practice guideline.
Journal ArticleDOI

LncRNA NKILA suppresses TGF-β-induced epithelial-mesenchymal transition by blocking NF-κB signaling in breast cancer.

TL;DR: The study indicated that the NKILA‐mediated negative feedback affects TGF‐β‐induced NF‐κB activation and that NKILA may be a therapeutic molecule in breast cancer metastasis via inhibition of EMT.
Journal ArticleDOI

Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version)

TL;DR: A working group of clinical experts and methodologists searched the literature for direct evidence on the management of COVID-19, and assessed its certainty generated recommendations using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.
Journal ArticleDOI

Identification of Biomarkers Correlated with the TNM Staging and Overall Survival of Patients with Bladder Cancer.

TL;DR: Several candidate biomarkers correlated with the TNM staging and overall survival of BC patients are identified and might be used as potential diagnostic biomarkers and therapeutic targets with clinical utility.